January 23, 2021

Volume XI, Number 23

Advertisement

January 22, 2021

Subscribe to Latest Legal News and Analysis

January 21, 2021

Subscribe to Latest Legal News and Analysis

January 20, 2021

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
21
May
Life Sciences Congressional Investigations: Trends, Traps and Tips Tycko & Zavareei LLP
21
May
Apotex Petitions Supreme Court to Review Therasense Standards Schwegman, Lundberg & Woessner, P.A.
21
May
Patent Safe Harbor Applies To Supplemental New Drug Applications Foley & Lardner LLP
20
May
Maker’s Marketing: Bourbon Distiller Racks up “Handmade” False Advertising Victory Proskauer Rose LLP
20
May
Alcohol Tax Breaks Brewing In Congress - May 2015 McBrayer, McGinnis, Leslie and Kirkland, PLLC
19
May
Private Lives v Saving Lives: Privacy Intrusions Of Little Consequence When Drug Testing in Australia Squire Patton Boggs (US) LLP
19
May
Federal Circuit Finds No Direct Infringement Of Akamai Patents Foley & Lardner LLP
18
May
The Sixth Circuit Reins in the Government's Measure of False Claims Act Damages Katten
18
May
Are Cosmetics Gaining Higher Congressional and FDA Scrutiny? Mintz
14
May
FDA Issues Guidance for Mobile Medical Apps McBrayer, McGinnis, Leslie and Kirkland, PLLC
14
May
More Biosimilar Q&A’s Released by FDA - Food and Drug Administration Mintz
14
May
Maker’s Mark Defeats “Handmade” Class Action Lawsuit McDermott Will & Emery
14
May
Employer’s Use of DNA Test to Catch Employee Engaging in Inappropriate Workplace Behavior Violates Federal Law Mintz
14
May
FDA Issues Final Guidance on Biosimilars Schiff Hardin LLP
14
May
First Look At False Marking Under The AIA - America Invents Act Foley & Lardner LLP
12
May
FDA Releases Additional Guidelines for Biosimilars Schiff Hardin LLP
12
May
California Supreme Court Scrutinizes Reverse Payment ANDA Settlements Foley & Lardner LLP
11
May
FDA Releases Draft Guidance on Using Clinical Data from Studies Conducted Outside the United States to Support Approval of Medical Devices Barnes & Thornburg LLP
11
May
Amarin Pharma Preemptively Sues FDA over First Amendment Rights Barnes & Thornburg LLP
8
May
Purdue Pharma v. Depomed: Denying Request for Rehearing Decision on Institution IPR2014-00379 Faegre Drinker

Pages

Advertisement
Advertisement

TRENDING LEGAL ANALYSIS

Advertisement